FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to pharmaceutical composition, containing compound of formula or for prevention or treatment of diseases, associated with oxidative stress, selected from group, consisting of MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke episodes), MERRF syndrome (myoclonic epilepsy with ragged red fibres) or Kearns-Sayre syndrome, arrhythmia, cardioplegia or myocardium infarction. in formula (1) na stands for 1 or 2, Aa represents 5-membered heteroaryl or heterocycle, each of which has 2 heteroatoms, selected from N, O and S, Rla represents R5a-Xa-Ba-X′a-, Ba represents direct bond, Xa and X′a independently on each other represent direct bond or -OC(O)-, R5a represents hydrogen or 6-9-membered monocyclic or condensed cyclic heterocycle or heteroaryl, each of which has from 1 to 3 heteroatoms, selected from N, O and S, and is optionally substituted with oxo or C1-C6-alkyl, R2a represents -(CR8aR9a)pa-Ya-R7a , pa stands for number from 0 or 1, Ya represents direct bond or -O-, R7a represents hydrogen or phenyl, R3a, R8a, R9a, R10a represent hydrogen, R4a represents -(CH2)pa-Da-R10a-, Da represents C5-cycloalkyl or 6-membered heterocycle, which has 1 heteroatom, selected from N, S and O. Radical values for formula (2) are give in invention formula.
EFFECT: obtaining compositions for prevention or treatment of diseases, associated with oxidative stress.
19 dwg, 5 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
INDOLE AND INDAZOLE COMPOUNDS AS CELLULAR NECROSIS INHIBITORS | 2008 |
|
RU2437883C1 |
INDOLE AND INDAZOLE DERIVATIVES SHOWING PRESERVING ACTION ON CELLS, TISSUES AND ORGANS | 2009 |
|
RU2460525C2 |
INDOLE COMPOUNDS AS CELL NECROSIS INHIBITORS | 2008 |
|
RU2477282C2 |
GLUCOKINASE ACTIVATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AS ACTIVE INGREDIENT | 2008 |
|
RU2450001C2 |
COMPOSITION FOR PREVENTING OR TREATING FATTY LIVER DISEASES | 2015 |
|
RU2664696C2 |
TRICYCLIC COMPOUNDS AS INHIBITORS OF IMMUNOSUPPRESSION MEDIATED BY TRYPTOPHAN METABOLIZATION | 2014 |
|
RU2667509C2 |
2-AMINO-BENZIMIDAZOLE DERIVATIVES AND USE THEREOF AS 5-LIPOXYGENASE AND/OR PROSTAGLANDIN E-SYNTHASE INHIBITORS | 2015 |
|
RU2732416C2 |
CONDENSED HETEROCYCLIC COMPOUND | 2009 |
|
RU2480473C2 |
INDOLYL-3-GLYOXYLIC ACID N-SUBSTITUTED AMIDES WITH ANTITUMOR EFFECT, MEDICINAL AGENT BASED ON THEREOF, METHOD FOR THEIR PREPARING AND METHOD FOR TREATMENT OF TUMOR DISEASE | 2004 |
|
RU2317293C9 |
5-5 CONDENSED RINGS AS C5a INHIBITORS | 2018 |
|
RU2780322C2 |
Authors
Dates
2015-07-20—Published
2010-10-25—Filed